MedReleaf Corp. (TSE:LEAF) had its price objective raised by Canaccord Genuity from C$15.00 to C$20.00 in a research note released on Tuesday.

MedReleaf Corp. (LEAF) opened at C$15.57 on Tuesday. MedReleaf Corp. has a twelve month low of C$6.81 and a twelve month high of C$18.90.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.dailypolitical.com/2017/11/17/medreleaf-corp-leaf-price-target-raised-to-c20-00.html.

In other news, insider Stephen Arbib sold 10,000 shares of MedReleaf Corp. stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of C$8.10, for a total transaction of C$81,000.00.

MedReleaf Corp. Company Profile

Receive News & Ratings for MedReleaf Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf Corp. and related companies with MarketBeat.com's FREE daily email newsletter.